Fritextsökning
Innehållstyper
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Tungviktare till Uppsalabolag
Tikomeds styrelse får ett riktigt proffs med i styrelsen.
-
Hon tar plats i Senzimes styrelse
Olinks marknadsdirektör är ny ledamot i Senzimes styrelse.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Martin Willner, Manager Lab, Nordic Service Manager, Mettler-Toledo AB
Why are you going to Scanlab+Biotech Forum?
-
Biden utser coronateam – hans rådgivare kritiserar Tegnell
USA:s nya president Joe Biden intar en helt ny hållning i bekämpningen av covid-19 än sin företrädare. Hans rådgivare Andy Slavitt kritiserade nyligen Anders Te...
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Ny chef på Bactiguard
I augusti tillträder Gabriella Björknert Caracciolo som ny CFO samt vice vd på Bactiguard.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Alzheimerläkemedlet lecanemab får godkännande i Kina
Det svenskutvecklade läkemedlet mot Alzheimers sjukdom, lecanemab, har fått ett marknadsgodkännande i Kina. Detta är det tredje godkännande för svenska Bioarcti...
-
Vinnova ger stöd till precisionsmedicin – här är projekten som får anslag
Vinnova anslår totalt 323 miljoner kronor i en stor satsning på precisionsmedicin.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Delseger i domstol för entreprenör som miste sitt bolag
Life science-profilen Mikael Kubista har vunnit rond 1 mot en advokatfirma som han tillsammans med andra delägare stämt för vårdslös rådgivning i samband med at...
BREAKING